About Index Trending news
Analyze
Pricing
KIYATEC

KIYATEC

KIYATEC

Leveraging advanced (3D, perfused, multi-tissue) cell culture to better predict human response to drugs and biomaterials through services & 3DKUBE products.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital
$180,000
Venture capital (Series A)
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when KIYATEC makes some noise.